Are you able to present your scientific idea in 3 minutes?
Are you a young researcher sitting on a great discovery, application or invention in life sciences?
Our expert public of around 900 scientists and entrepreneurs would like to hear from you! The HealthCapital – healthcare industries cluster Berlin-Brandenburg – and the Interest Group Biotechnology of the German Association of Research Based Pharmaceutical Companies (vfa bio) are awarding the BIONNALE Speed Lecture Award!
Present your idea in 3 minutes in a layman´s language!
Get a coaching from an experienced and professional coach on how to do a brilliant pitch as a finalist at Ludwig Erhard Haus, Berlin. The date will be published soon.
As the winner of our Speed Lecture Award on June 20, 2018 save your prize of
1,000€ for first place,
500€ for second place,
300€ for third place
April 11, 2018
Send your PowerPoint Slides in English, a short description of your project and a short introduction of yourself to:
Dr. Jasmin Podufall, Berlin Partner for Business and Technology GmbH: firstname.lastname@example.org
Please bear in mind that your application needs to be authorized by the group leader if the work of a research group is presented.
A jury consisting of carefully selected regional experts and decision makers in life sciences will select the finalists. The evaluation criteria are originality, relevance and the presentation of the idea.
The finalists will present their Speed Lecture at the
June 20, 2018
Ludwig Erhard Haus, Berlin.
The winner will be selected by audience voting.
What is the Speed Lecture Award?
Six young scientists present in three minutes their new projects and ideas in life sciences and healthcare industries in front of the BIONNALE audience of around 900 experts from academia, science and business. The winner will be selected by audience voting.
The Speed Lecture Award was initiated by the healthcare industries cluster Berlin-Brandenburg – HealthCapital and the interest group biotechnology within the German Association of Research-based Pharmaceuticals, vfa bio and is supported by both partners.